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Abstract
Background: Minimal deviation adenocarcinoma (MDA) of the uterine cervix is defined as an extremely well 
differentiated variant of cervical adenocarcinoma, with well-formed glands that resemble benign glands but show 
distinct nuclear anaplasia or evidence of stromal invasion. Thus, MDA is difficult to differentiate from other cervical 
hyperplastic lesions. Monoclonality is a major characteristic of most tumors, whereas normal tissue and reactive 
hyperplasia are polyclonal.
Methods: The clinicopathological features and clonality of MDA were investigated using laser microdissection and a 
clonality assay based on the polymorphism of androgen receptor (AR) and X-chromosomal inactivation mosaicism in 
female somatic tissues. 
Results: The results demonstrated that the glands were positive for CEA, Ki-67, and p53 and negative for estrogen 
receptor (ER), progesterone receptor (PR), and high-risk human papilloma virus (HPV) DNA. The index of proliferation 
for Ki-67 was more than 50%. However, the stromal cells were positive for ER, PR, vimentin, and SM-actin. The clonal 
assay showed that MDA was monoclonal. Thus, our findings indicate that MDA is a true neoplasm but is not associated 
with high-risk HPV.
Conclusions: Diagnosis of MDA depends mainly on its clinical manifestations, the pathological feature that MDA 
glands are located deeper than the lower level of normal endocervical glands, and immunostaining.
Background
Minimal deviation adenocarcinoma (MDA) of the uterine
cervix, also known as adenoma malignum, is defined as
an extremely well-differentiated variant of cervical ade-
nocarcinoma. One percent to 3% of all cervical glandular
malignancies fit this definition [1]. Distorted glands are
the main component of these malignancies, while the
stromal spindle cells are responsive hyperplasia. The
diagnosis of MDA is based on histopathological charac-
teristics--the presence of well-formed glands and stromal
invasion--and immunophenotype: CEA positive reactiv-
ity and a high proliferative index of Ki-67. However, MDA
is difficult to differentiate from benign hyperplastic
lesions such as microglandular hyperplasia, adenomatous
hyperplasia, diffuse laminar endocervical glandular
hyperplasia, and lobular endocervical glandular hyper-
plasia. Monoclonality is a major characteristic of most
tumors. By contrast, normal tissue and reactive hyperpla-
sia are polyclonal [2]. The clonality of MDA has not been
reported in the literature. Therefore, we sought to eluci-
date its clonality using laser microdissection and a clonal-
ity assay based on the polymorphism of androgen
receptor (AR) and X-chromosomal inactivation mosa-
icism in female somatic tissues. At the same time, we
investigated MDA's clincopathological features and
immunohistochemical characteristics.
Materials and methods
Samples
All seven cases of samples, including 3 cases of MDA, 1
adenomatous hyperplasia, and 3 hysteromyoma (con-
trols), were collected between January 2008 and Septem-
ber 2009 from Tangdu Hospital, the Fourth Military
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Medical University (Xi'an, China). The study protocol
was approved by the Medical Ethics Commission of the
Fourth Military Medical University in Xi'an. All samples
were surgically resected, fixed in 4% formaldehyde, and
embedded in paraffin. Serial sections were cut and
stained with hematoxylin and eosin (HE). Each case was
examined by three pathologists and diagnosed according
to the morphological criteria for MDA, adenomatous
hyperplasia, and hysteromyoma.
Immunohistochemistry
Immunostaining was carried out using a streptavidin-
labeled peroxidase (S-P) kit (KIT9730) according to the
manufacturer's instructions. The primary antibodies
used in this study included mouse anti-human monoclo-
nal antibodies (mAb) against carcinoembryonic antigen
(CEA), cytokeratin (CK)18, cancer antigen (CA)125,
estrogen receptor (ER), desmin, Ki-67, p53, and proges-
terone receptor (PR); rabbit anti-human polyclonal anti-
bodies against S-100 protein and smooth muscle actin
(SM-actin); and mouse anti-pig mAb against vimentin.
All of the reagents for immunostaining were supplied by
Maixin Biotechnology Corporation Limited, Fuzhou,
China.
In situ hybridization
In situ hybridization for high-risk human papillomavirus
(HPV) was performed using a commercially available
biotinylated HPV DNA probe mixture for HPV types 16
and 18 (Panpath, Holland) according to the manufac-
turer's instructions. Briefly, a 4-μm-thick formalin-fixed,
paraffin-embedded sample tissue section was deparaffi-
naged in xylene and pretreated by microwave irradiation
and pepsin digestion at 37°C for 30 minutes. Approxi-
mately 4 μL of the HPV DNA probe mixture was dropped
on a pretreated sample tissue section, denatured at 95°C
for 5 minutes, and hybridized at 37°C for 16 hours using a
programmable temperature control system (Thermo-
Brite, USA). The slide was washed, incubated with
streptavidin-alkaline phosphatase solution (Maixin), and
then visualized with nitroblue tetrazolium/bromo-4-
chloro-3-indolyphosphatase. For the evaluation, samples
were considered positive for high-risk HPV when >10% of
glandular or cancerous cell nuclei were stained positively.
Microdissection and DNA extraction
Eight 10-μm tissue sections (1.0 × 1.0 cm2), obtained
from representative paraffin blocks, were placed on a
UV-absorbing membrane and underwent laser microdis-
section by LMD6000 (Leica Microsystems Ltd., Wetzlar,
Germany). After HE-staining, the slides were mounted
on a microstat, and the distorted glands were then dis-
sected by UV laser using the motorized optical-beam
scanning mode (Figure 1). The dissected (with the
attached specimen) was dropped by gravity into the cap
of 0.5-mL microcentrifuge tube filled with 40 μL lysate
buffer and 10 μL proteinase K. For each dissected lesion,
stromal cells of approximately the same area were iso-
lated and analyzed as a control. The microcentrifuge
tubes were then placed in a water bath (48°C) to digest
the tissues. After digestion for 12 to 20 h, genomic DNA
was extracted and examined by 2% agarose gel electro-
phoresis, then stored at -20°C.
Polymerase chain reaction (PCR) amplification for clonal 
assay
Nested PCR was used to amplify detection of the length
polymorphism of CAG short-tandem repeat (STR) in
exon 1 of the AR gene loci as described previously [3].
The genomic DNA extracted from lesions and from from
non-lesion tissues (for the AR gene, 10 μL each) was incu-
bated with 5 U of Hha I (Promega, Madison, WI, USA) at
37°C for 3 h in a volume of 20 μL containing 2 μL of 10×
reaction buffer. The digested DNA samples, 1 μL each,
were then subjected to nested PCR. The reaction mixture
was 50 μL in volume, containing 4 μL of 10 mM dNTP
(Gibco BRL, Life Technologies, Inc., Gaithersburg, MD,
USA), primers AR1A and AR1B (20 μM each), and 5 μL
of 10× buffer, 1.5 μL of 50 mM MgCl2, and 2.5 U of Taq
DNA polymerase (Gibco BRL). The amplification was
conducted using a PT-200 thermocycler (MJ Research,
Inc., Watertown, MA, USA) for 25 cycles (94°C for 40 sec,
56°C for 50 sec, and 72°C for 1 min). For the second
round, PCR products (1 μL) were used as templates for a
second PCR reaction using primers AR2A and AR2B.
The amplification procedure was the same as that in the
first round. Finally, the amplification efficiency was
checked by resolving PCR reaction aliquots on 2% aga-
rose gels. The PCR products, 4 μL for each, were also
mixed with the same volume of loading buffer (1 g/L
xylene cyanole, 1 g/L bromophenol blue, in formamide)
and resolved on an 8% polyacrylamide gel containing 8
mol/L urea using the Mini-VE system (Amersham Biosci-
ences, San Francisco, CA, USA) at 120 V for 4 h. Bands
were visualized using silver staining.
Analysis and assessment of PCR products for clonal assay
Images of PCR gels were recorded, and the intensities of
the PCR bands for both alleles were quantitated using an
image-analyzing system (LabWorks 3.0, UVP, Cambridge,
UK). A reduction in fluorescence intensity of at least 50%
for either band, as compared with the intensity of the
bands obtained in the absence of Hpa I digestion, was
used as indicator of loss of X chromosome inactivation
mosaicism [3]. A corrected ratio (CR) was calculated by
the ratio of the upper-band intensity to the lower-band
intensity, or vice-versa, of the same sample before and
after digestion to give a CR value >1. In the present study,Gong et al. Diagnostic Pathology 2010, 5:25
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a CR value ≥ 2 was used to define loss of X chromosome
inactivation mosaicism.
Results
Pathological observation
Microscopically, lesions were characterized by mucinous
glands that resembled normal endocervical glands but
showed distinct nuclear anaplasia or evidence of stromal
invasion. Mitotic figures was found (Figure 2).
Immunohistochemical analysis
It showed that CEA, Ki-67 and p53 were expressed in the
glandular epithelium of MDA, but not in the normal cer-
vical tissues (Figure 3). Moreover, the normal cervical tis-
sues and stromal cells were found to be positive for ER
and PR, but the glandular epithelium were negative for
these receptors (Figure 4). Stromal cells were also positive
for SM-actin and vimentin in both MDA and the normal
cervical tissues, but stromal cells with SM-actin positive
reactivity were more abundant in MDA than in the nor-
mal cervical tissues (Figure 5).
In situ hybridization
As for in situ hybridization, all 3 MDAs examined were
negative for high-risk HPV DNA, but blue grandular
nuclei were found in the cervical tissue with positive con-
trol for HPV types 16 or 18.
Clonality determination
The clonality assay demonstrated polymorphism for all
the samples at AR loci. Before digestion by Hha I, PCR
gels of DNA samples obtained from glandular epithelium
Figure 1 A distorted gland before laser microdissection (1A); after laser microdissection (1B).
Figure 2 Histopathological characteristics of MDA. Microscopically, the lesion was characterized by mucinous glands which resembled normal 
endocervical glands, but showing distinct nuclear anaplasia or evidence of stromal invasion (A). Mitotic figures might be found (B). (A, Magnification 
× 100; B, Magnification × 400)Gong et al. Diagnostic Pathology 2010, 5:25
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showed two AR bands. After Hha I digestion, one band
was no longer evident. However, regardless of Hha  I
digestion, the intensities of the two bands were equal for
all the stromal cells, the case of adenomatous hyperplasia,
and the 3 cases of normal cervical tissues (Figure 6). This
result suggests that MDA can be interpreted as a neoplas-
tic hyperplasia.
Discussion
Minimal deviation adenocarcinoma (MDA) of the uterine
cervix, also known as adenoma malignum, is a highly dif-
ferentiated form of adenocarcinoma, representing about
1% to 3% of all endocervical adenocarcinomas [1]. It was
first described as adenoma malignum by Gusserow in
1870 [4]. The term "minimal deviation adenocarcinoma"
for extremely well-differentiated adenocarcinoma of the
uterine cervix was proposed by Silverberg and Hurt in
1975 [5].
The average age of patients described in the literature
ranges from 42.6 to 53.3 years, and the youngest patient
reported was 16 years [6,7]. The average age of our three
patients was 39 years. The most common presenting
symptoms (in decreasing order of frequency) were watery
discharge, menometrorrhagia, irregular genital bleeding,
and abdominal swelling.
Human papillomavirus (HPV) is widely considered to
be related to cervical carcinogenesis, and it is always
detected in squamous cell carcinoma and its precursors.
The oncoproteins E6 and E7, which are encoded in high-
risk HPV types 16 and 18, typically are found in these
lesions. A high incidence of HPV also has been reported
in adenocarcinoma and adenocarcinoma in situ of the
u t e r i n e  c e rv i x  [ 8 , 9 ] .  H o w e v e r ,  r e c e n t  s t u d i e s  t h a t  h a v e
reported a rather low incidence of HPV in MDAs suggest
that MDA is probably not related to HPV infection
[10,11]. In this study, we investigated HPV infection in
MDA using in-situ hybridization technique, but we did
not find glandular nuclei that were positive for high-risk
HPV, a negative finding compatible with those of previ-
ous studies. McGowan et al. [12] have reported that
Figure 3 The immunohistochemical staining of CEA and Ki-67. The expression of CEA and Ki-67 were found in the glandular epithelium of MDA 
(A, C), respectively, but no in the normal cervical tissues (B, D).Gong et al. Diagnostic Pathology 2010, 5:25
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Peutz-Jeghers syndrome, a rare hereditary autosomal dis-
order characterized by benign hamartomatous polyposis
in the gastrointestinal tract and mucocutaneous pigmen-
tation, accompanied by ovarian mucinous tumors, may
sometimes be complicated by MDA. However, our
patients included no cases of Peutz-Jeghers syndrome.
The diagnosis of MDA is based on histopathological
characteristics and immunophenotype. Microscopically,
Figure 4 The immunohistochemical staining of ER and PR. ER and PR were found to be positive in the normal cervical tissues and stromal cells (B, 
D), but negative in the glandular epithelium and positive in the stromal cells of MDA (A, C).
Figure 5 The immunohistochemical staining of SM-actin. The stromal cells were also positive for SM-actin in both MDA and the normal cervical 
tissues, but the stromal cells with SM-actin positive reactivity were more abundant in MDA (A) than in the normal cervical tissues (B).Gong et al. Diagnostic Pathology 2010, 5:25
http://www.diagnosticpathology.org/content/5/1/25
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the glands are irregular in size and shape and lined pre-
dominantly by mucin-containing columnar epithelial
cells with basal nuclei. Moreover, they typically exhibit
deep invasion of the cervical wall. Immunohistochemi-
cally, glands are positive for CEA and Ki-67 but negative
for ER, PR, and CA125. In our study, the results of histo-
pathological and immunohistochemical observation were
compatible with this description. In addition, we found
that ER and PR were expressed in the stromal cells of
both MDA and normal cervical tissues, a finding not
described in the literature. However, it is almost impossi-
ble to histologically differentiate these tumor glands from
normal endocervical glands, because the tumor glands of
MDA are highly differentiated. Monoclonality is one of
the main features of most tumors, whereas normal and
reactive hyperplastic lesions are polyclonal [2]. The clon-
ality assay we used is based on X-chromosome inactiva-
tion mosaicism and polymorphism at the AR loci in
female somatic cells. Each female somatic cell contains
two X chromosomes, one of which is inactivated ran-
domly by methylation during early embryogenesis, while
the other preserves its genetic activity throughout life. AR
polymorphism shows different lengths of the CAG short-
tandem repeat (STR) at exon 1 [13]. After digestion with
the methylation-sensitive restriction enzymes Hha I, the
normal and reactive hyperplastic tissues with polymor-
phism show two alleles with equal intensity. Neoplastic
tissues show only one of the two alleles, with obviously
reduced intensity [2].
In our study, the result of the clonal assay demonstrated
that MDA was a neoplastic lesion, whereas adenomatous
hyperplasia and normal cervical tissues were polyclonal,
further confirming the nature of MDA. Understanding
this distinction will help clinicians to differentiate MDA
from benign hyperplastic lesions such as microglandular
hyperplasia, adenomatous hyperplasia, diffuse laminar
endocervical glandular hyperplasia, and lobular endocer-
vical glandular hyperplasia.
PCR-based clonality analysis occasionally produces a
pseudomonoclonal or pseudopolyclonal result [14]. The
major mechanism responsible for the pseudomonoclonal
result is patch size [15,16]. If progeny cells remain adja-
cent to each other after cell division, large patches of cells
are formed, all of which contain an identical pattern of X-
chromosome inactivation. Lesions arising from two,
three, or more cells within a patch will show the same
p a t t e r n  o f  X - c h r o m o s o m e  i n a c t i v a t i o n  a n d  w i l l  t h u s
appear monoclonal. This concept is a particularly impor-
tant consideration when using very small tissue samples
obtained by microdissection. To avoid this problem,
Diaz-Cano et al. [14] recommend using sample sizes
larger than 100 cells or 0.25 cm2. Although we performed
laser microdissection in our study to obtain the pure
glands, the sample was composed of numerous different
glands, and sample sizes were about 1000 cells. The rea-
son for pseudopolyclonal results is likely contamination
caused by a heavy inflammatory cell infiltrate or inadver-
tent inclusion of stromal cells. We used laser microdis-
section to avoid this circumstance. Therefore, we believe
that our result is reliable. However, additional studies
with larger sample sizes are necessary to conclusively
prove our hypothesis.
In su m ma ry ,  M D A is  a  hi ghl y diff er e n t ia t ed f orm  of
adenocarcinoma. The results of clonal assay indicate that
MDA is a true neoplasm but is not associated with high-
risk HPV. Diagnosis of MDA mainly depends on its clini-
cal manifestations and the pathological feature that MDA
glands are located deeper than the lower level of normal
endocervical glands. Immunostaining is extremely help-
ful in diagnosing MDA.
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Figure 6 Electropherogram on 8% polyacrylamide gel. On the AR 
PCR gel pictures, there was two bands before DNA samples obtained 
from glandular epithelium was digested by Hha I. In contrast, one band 
disappeared after the DNA samples of the glandular epithelium was di-
gested by Hha I. However, the intensities of the two bands were equal 
for a case of adenomatous hyperplasia and three cases of normal cer-
vical tissues with or without Hha I digestion -, pretreated without Hha 
I; +, pretreated with Hha I; M, DNA marker. T1-T3, MDA tissues from 3 
different female patients. AH, adenomatous hyperplasia.Gong et al. Diagnostic Pathology 2010, 5:25
http://www.diagnosticpathology.org/content/5/1/25
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